FeesSafety
Pluang+

Rogers Communications posts 1% revenue and EBITDA growth, achieves record $1.4B free cash flow in Q3 2026

Company Fundamentals
23 Oct 2026
GlobeNewsWire
View Source
Bullish
Rogers Communications posts 1% revenue and EBITDA growth, achieves record $1.4B free cash flow in Q3 2026

Rogers Communications reported a 1% increase in total service revenue and adjusted EBITDA for Q3 2026, alongside a record free cash flow of $1.4 billion. The company completed full ownership of Maple Leaf Sports & Entertainment (MLSE) and plans to sell a minority stake in its sports and media assets to reduce debt. Wireless revenue dipped slightly due to competitive pressures, but margins improved, while Media revenue rose 9%, boosted by strong sports attendance. Rogers reaffirmed its 2026 financial outlook and aims to further deleverage by mid-2027.

Rogers Communications' Q3 2026 results provide context for media sector performance. For readers following the media sector, here is Pluang's market snapshot as of Oct 23, 2026 18:02 WIB: Of 58 priced US media stocks, 15 rose and 39 fell. Notable prices include DoorDash Inc (DASH) at USD 184.38 with a 1-day change of -0.84%, Walt Disney Co (DIS) at USD 112.29 with 99% sell order activity, and Meta Platforms Inc (META) at USD 644.12 with a 48% sell / 52% buy split.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
17 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App